As suggested in recent ALL guidelines, severe AAP patients (severe pancreatitis with amylase elevation >3 times the UNL, accompanied with pseudocyst within 48 hours) were not allowed to receive any asparaginase as a prospective chemotherapy regimen (6, 22). This evidence concerns the gene ASPG and acute lymphoblastic leukemia.